Please use this identifier to cite or link to this item: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/4116
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFALASE, E. A. O.-
dc.contributor.authorOTOLORIN, E . O-
dc.contributor.authorLADIPO, O. A.-
dc.date.accessioned2025-05-15T09:13:03Z-
dc.date.available2025-05-15T09:13:03Z-
dc.date.issued1988-
dc.identifier.citationAfr J Med Med Sci 1988, 17(4):209-213en_US
dc.identifier.issn1116-4077-
dc.identifier.urihttp://adhlui.com.ui.edu.ng/jspui/handle/123456789/4116-
dc.descriptionArticleen_US
dc.description.abstractEight hundred and ten patients who accepted to use depo-medroxyprogesterone acetate (DMPA) for contraception were studied over a period of 11 years (1976-1986). Important side-effects observed were amenorrhoea (36.3%), weight gain (15.8%), weight loss (10.6%), metrorrhagia (6.7%) and menorrhagia (6.0%). Amenorrhoea, menorrhagia and metrorrhagia were major reasons for discontinuation of DMPA in 11% of acceptors. There were no cases of pregnancy, genital or breast malignancies during DMPA use. Our experience indicates that DMPA as a contraceptive is effective and should be available for suitable clients who demonstrate oestrogen intolerance.en_US
dc.description.sponsorshipCOLLEGE OF MEDICINE, UNIVERSITY OF IBADAN, NIGERIAen_US
dc.language.isoenen_US
dc.publisherCOLLEGE OF MEDICINE, UNIVERSITY OF IBADAN, NIGERIAen_US
dc.subjectdepo-medroxyprogesterone acetateen_US
dc.subjectNigerian populationen_US
dc.titleExperience with the use of depo-medroxyprogesterone acetate in a Nigerian populationen_US
dc.typeArticleen_US
Appears in Collections:African Journal of Medicine and Medical Sciences

Files in This Item:
File Description SizeFormat 
Falase et al_Experience_1988.pdfArticle7.63 MBAdobe PDFView/Open
AUTHOR INDEX.pdfAuthor Index3.55 MBAdobe PDFView/Open


Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.